from www.streetinsider.com:
>>Jefferies is maintaining their Buy rating on shares of Accuray (NASDAQ: ARAY) following their recent announcement on their plans to acquire TomoTherapy Incorporate.
Monday, March 14, 2011
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment